FI965116A0 - Uusia opioidipeptidiantagonisteja - Google Patents

Uusia opioidipeptidiantagonisteja

Info

Publication number
FI965116A0
FI965116A0 FI965116A FI965116A FI965116A0 FI 965116 A0 FI965116 A0 FI 965116A0 FI 965116 A FI965116 A FI 965116A FI 965116 A FI965116 A FI 965116A FI 965116 A0 FI965116 A0 FI 965116A0
Authority
FI
Finland
Prior art keywords
peptide antagonists
opioid peptide
new opioid
new
antagonists
Prior art date
Application number
FI965116A
Other languages
English (en)
Swedish (sv)
Other versions
FI965116A (fi
Inventor
Peter Schiller
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9402170A external-priority patent/SE9402170D0/xx
Priority claimed from SE9402838A external-priority patent/SE9402838D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI965116A0 publication Critical patent/FI965116A0/fi
Publication of FI965116A publication Critical patent/FI965116A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI965116A 1994-06-20 1996-12-19 Uusia opioidipeptidiantagonisteja FI965116A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9402170A SE9402170D0 (sv) 1994-06-20 1994-06-20 New compounds
SE9402838A SE9402838D0 (sv) 1994-08-25 1994-08-25 New compounds
PCT/SE1995/000721 WO1995035316A1 (en) 1994-06-20 1995-06-14 New opioid peptide antagonists

Publications (2)

Publication Number Publication Date
FI965116A0 true FI965116A0 (fi) 1996-12-19
FI965116A FI965116A (fi) 1996-12-19

Family

ID=26662082

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965116A FI965116A (fi) 1994-06-20 1996-12-19 Uusia opioidipeptidiantagonisteja

Country Status (8)

Country Link
US (1) US5733881A (fi)
JP (1) JPH10501807A (fi)
CA (1) CA2192484A1 (fi)
FI (1) FI965116A (fi)
IL (1) IL114046A0 (fi)
NO (1) NO965457D0 (fi)
NZ (1) NZ288775A (fi)
WO (1) WO1995035316A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US6284769B1 (en) 1999-12-03 2001-09-04 The Board Of Trustees Of The University Of Illinois Nonpeptide kappa opioid receptor antagonists
EP1613597B1 (en) 2003-03-07 2007-11-07 Eli Lilly and Company 6-substituted nicotinamide derivatives as opioid receptor antagonists
WO2005016889A1 (en) * 2003-08-08 2005-02-24 Virginia Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties
US7601739B2 (en) 2003-08-08 2009-10-13 Virgina Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides

Also Published As

Publication number Publication date
NO965457L (no) 1996-12-18
AU2811495A (en) 1996-01-15
IL114046A0 (en) 1995-10-31
US5733881A (en) 1998-03-31
AU691630B2 (en) 1998-05-21
FI965116A (fi) 1996-12-19
JPH10501807A (ja) 1998-02-17
NO965457D0 (no) 1996-12-18
CA2192484A1 (en) 1995-12-28
NZ288775A (en) 1998-02-26
WO1995035316A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
IS4664A (is) Ný peptíð-ópíóíð
FI971685A (fi) Takykiniini-antagonisteja
EE9600186A (et) Neurokiniini (tahhüülkiniini) antagonistid
DK0738150T3 (da) Bicykliske fibrinogene antagonister
PT805813E (pt) Antagonistas de vasopressina triciclicos
DE69831176D1 (de) Kappa rezeptor opioid peptide
DE69734833D1 (de) Vitronektin rezeptor antagonisten
ATE381570T1 (de) Trizyclische benzazepin-vasopressin-antagoniste
NO985680D0 (no) Peptidderivater
LV10962A (lv) Jauni peptidi
IS4459A (is) Ný peptíð er hafa ónæmisbreytandi áhrif
ATE232526T1 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
NO983849D0 (no) Peptidderivater
FI970168A0 (fi) Peptidejä
DE69513832D1 (de) Exzitatorische aminosäure-rezeptor-antagonisten
ATE290546T1 (de) Tachykinin antagoniste
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
FI965116A (fi) Uusia opioidipeptidiantagonisteja
FI950211A0 (fi) Huokosia muodostavia peptidejä Geolycosa riograndesta
IL113441A0 (en) Opioid peptide analoog
KR970702876A (ko) 뉴로키닌 길항제(Neurokinine (tachykinine) antagonists)
KR950027351U (ko) 반목 항타장치
DK0964867T3 (da) Tachykininantagonister
ZA954311B (en) New oploid peptide antagonists
ZA9510618B (en) Tachykinin antagonists